The Latest Breaking News from Raymond James

Raymond James analyst Simon Leopold double upgraded Cambium Networks Corp (NASDAQ:CMBM) to Strong Buy from Market Perform with a $35 price target, implying an upside of 57.6%. Leopold believes fundamental demand remains solid, with temporary supply chain constraints depressing near-term results.  He tells investors in a research note that checks indicate that elements of the…

Analysts mostly hailed Visa Inc's (NYSE:V) Q1 FY22 results by raising their price targets on the stock. Raymond James analyst John Davis raised the price target to $281 from $265 (36.3% upside) and maintained an Outperform.  Visa's Q1 print included better than expected results across the board as well as an increased FY22 outlook that should send…

Alibaba Group Holding Limited's (NYSE: BABA) travails are far from over, at least in the near term, although its long-term future is promising, an analyst at Raymond James said in a Wednesday note. 

Raymond James cut DexCom, Inc. (NASDAQ: DXCM) price target from $618 to $538. DexCom shares rose 1.1% to $434.60 in pre-market trading.